Cosyntropin Injection, Powder, Lyophilized, For Solution
Product Images NDC 51662-1567

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cosyntropin (NDC 51662-1567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

Chemical structure diagram showing the amino acid sequence of Cosyntropin, listing the residues from Serine to Proline over 24 positions.*

FDA Label Image

Serialized Labeling (Serialized Labeling)

Vial of Cosyntropin for Injection, 0.25 mg/vial, lyophilized powder for solution. The label indicates it is for intravenous or intramuscular use and for diagnostic use only. The vial has a yellow cap and is distributed by HF Acquisition Co. LLC, with Sandoz branding visible on the label. The product NDC on the vial is 0781-3440-71.*

FDA Label Image

Vial Labeling (Vial Labeling)

Label for Cosyntropin for Injection 0.25 mg/vial, a lyophilized powder for intravenous use. The label includes dosage instructions, storage conditions, and a barcode. The product is labeled by Sandoz, intended for diagnostic use only, and requires reconstitution before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.